Shares of Aurora Cannabis Inc. (TSE:ACB) saw a slight increase of 0.2% on Thursday, trading at C$5.90 after reaching a high of C$5.97 earlier in the session. A total of 506,480 shares exchanged hands, which represented a 17% decline from the average trading volume of 611,648 shares. The stock had closed at C$5.89 in the previous session.
Analysts Adjust Price Targets
In a recent analysis, ATB Capital revised its target price for Aurora Cannabis, lowering it from C$9.00 to C$8.50 while maintaining an “outperform” rating. Currently, one analyst has issued a Strong Buy rating, and another has given a Buy rating to the company. According to data from MarketBeat, the overall consensus rating for Aurora Cannabis stands at “Strong Buy” with an average target price of C$8.50.
The company last reported its quarterly earnings on November 5, 2023. During this period, Aurora Cannabis recorded an earnings per share (EPS) of C($0.91). The firm experienced a negative net margin of 22.55% and a negative return on equity of 8.36%. Revenue for the quarter totaled C$90.37 million. Analysts predict that for the current fiscal year, Aurora Cannabis will report an EPS of -C$0.22.
Company Overview and Market Position
Headquartered in Edmonton, Canada, Aurora Cannabis cultivates and sells both medicinal and recreational cannabis through a diverse range of brands, including Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. While its primary operations are based in Canada, the company has expanded its reach internationally, establishing medical cannabis export agreements and cultivation facilities in over 20 countries.
The current trading environment for cannabis stocks remains dynamic, with investors closely monitoring Aurora Cannabis’s performance as it navigates through financial challenges and evolving market conditions. The adjustments in analyst ratings and price targets reflect ongoing assessments of the company’s potential for recovery and growth within the competitive cannabis industry.
For those interested in staying updated, MarketBeat offers a daily email newsletter summarizing the latest news and analyst ratings for Aurora Cannabis and related companies.
